Order Article Reprints

Alhadrami HA, Sayed AM, Hassan HM, Youssif KA, Gaber Y, Moatasim Y, Kutkat O, Mostafa A, Ali MA, Rateb ME, et al. Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics. Antibiotics. 2021; 10(5):542. https://doi.org/10.3390/antibiotics10050542

Alhadrami, Hani A., Ahmed M. Sayed, Hossam M. Hassan, Khayrya A. Youssif, Yasser Gaber, Yassmin Moatasim, Omnia Kutkat, Ahmed Mostafa, Mohamed Ahmed Ali, Mostafa E. Rateb, and et al. 2021. "Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics" Antibiotics 10, no. 5: 542. https://doi.org/10.3390/antibiotics10050542

Alhadrami, H. A., Sayed, A. M., Hassan, H. M., Youssif, K. A., Gaber, Y., Moatasim, Y., Kutkat, O., Mostafa, A., Ali, M. A., Rateb, M. E., Abdelmohsen, U. R., & Gamaleldin, N. M. (2021). Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics. Antibiotics, 10(5), 542. https://doi.org/10.3390/antibiotics10050542